Other
Concussion
17
Pipeline Programs↗
6
Active Trials↗
8
Companies Involved↗
Concussion is an emerging landscape with 17 programs across 8 companies. The most active players are COMPASS Pathways, Viatris Specialty LLC, Micelle BioPharma Inc. 4 therapies are approved.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical2
Phase 17
Phase 24
Phase 3
No programs
Analysis
Trial Status
22
clinical trials
Completed11 · 50%
Recruiting5 · 23%
Terminated2 · 9%
Unknown status2 · 9%
Withdrawn1 · 5%
Not yet recruiting1 · 5%
Clinical Trials
Trial Activity
22 trials
BCAAs in Concussion 2.0
Recruiting·—·Phase 2·NCT06829498·150 enrolled
HIT HEADS 3.0: Head Injury Treatment: A Randomized, Placebo-controlled, Double-blinded, Therapeutic Clinical Trial of Branched Chain Amino Acids (BCAAs) in the Treatment of Concussion
Not yet recruiting·—·Phase 2·NCT07670195·150 enrolled
Ghrelin (OXE--103) for Acute Concussion Management
Completed·—·Phase 2·NCT04558346·23 enrolled
High Dose Omega-3 Fatty Acids in the Treatment of Sport Related Concussions
Completed·—·N/A·NCT01814527·62 enrolled
BCAA Supplementation for Concussion
Completed·—·Phase 2·NCT01860404·42 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)